Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X

1428243-27-9 manufacturers and suppliers on PharmaCompass

PharmaCompass
1428243-27-9
Also known as: 1428243-27-9, Xaj442my8s, Schembl14791218, Bfrdsfzfzqjxhn-vpusjebwsa-n, Dtxsid801098880, (3r,4s)-benzyl 3-(2-(tert-butoxycarbonyl(5-tosyl-5h-pyrrolo[2,3-b]pyrazin-2-yl)amino)acetyl)-4-ethylpyrrolidine-1-carboxylate
Molecular Formula
C34H39N5O7S
Molecular Weight
661.8  g/mol
InChI Key
BFRDSFZFZQJXHN-VPUSJEBWSA-N
FDA UNII
XAJ442MY8S

1 2D Structure

1428243-27-9

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
benzyl (3S,4R)-3-ethyl-4-[2-[[5-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyrazin-2-yl]-[(2-methylpropan-2-yl)oxycarbonyl]amino]acetyl]pyrrolidine-1-carboxylate
2.1.2 InChI
InChI=1S/C34H39N5O7S/c1-6-25-19-37(32(41)45-22-24-10-8-7-9-11-24)20-27(25)29(40)21-38(33(42)46-34(3,4)5)30-18-35-31-28(36-30)16-17-39(31)47(43,44)26-14-12-23(2)13-15-26/h7-18,25,27H,6,19-22H2,1-5H3/t25-,27+/m1/s1
2.1.3 InChI Key
BFRDSFZFZQJXHN-VPUSJEBWSA-N
2.1.4 Canonical SMILES
CCC1CN(CC1C(=O)CN(C2=CN=C3C(=N2)C=CN3S(=O)(=O)C4=CC=C(C=C4)C)C(=O)OC(C)(C)C)C(=O)OCC5=CC=CC=C5
2.1.5 Isomeric SMILES
CC[C@@H]1CN(C[C@@H]1C(=O)CN(C2=CN=C3C(=N2)C=CN3S(=O)(=O)C4=CC=C(C=C4)C)C(=O)OC(C)(C)C)C(=O)OCC5=CC=CC=C5
2.2 Other Identifiers
2.2.1 UNII
XAJ442MY8S
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 1428243-27-9

2. Xaj442my8s

3. Schembl14791218

4. Bfrdsfzfzqjxhn-vpusjebwsa-n

5. Dtxsid801098880

6. (3r,4s)-benzyl 3-(2-(tert-butoxycarbonyl(5-tosyl-5h-pyrrolo[2,3-b]pyrazin-2-yl)amino)acetyl)-4-ethylpyrrolidine-1-carboxylate

7. Benzyl (3r,4s)-3-(n-(tert-butoxycarbonyl)-n-(5-tosyl-5h-pyrrolo[2,3-b]pyrazin-2-yl)glycyl)-4-ethylpyrrolidine-1-carboxylate

8. Phenylmethyl (3r,4s)-3-[2-[[(1,1-dimethylethoxy)carbonyl][5-[(4-methylphenyl)sulfonyl]-5h-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-4-ethyl-1-pyrrolidinecarboxylate

2.4 Create Date
2015-02-02
3 Chemical and Physical Properties
Molecular Weight 661.8 g/mol
Molecular Formula C34H39N5O7S
XLogP35
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count9
Rotatable Bond Count12
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area149
Heavy Atom Count47
Formal Charge0
Complexity1210
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
5034-06-0
Upadacitinib
Since 2010, our dedication to our clientele has been unwavering in addressing pharmaceutical hurdles, reg...
Since 2010, our dedication to our clientele has been unwavering in addressing pharmaceutical hurdles, regardless of scale. We prioritize integrity, responsiveness, and punctuality, embedding our values into every endeavor. Our aim is to cultivate mutually beneficial relationships with customers, suppliers, and ourselves, fostering sustainable growth. Empowered by visionary leadership and a quality-driven team, ASolution is steadfast in providing innovative solutions to challenges such as Process Development, Optimization, Drug Product and Substance Manufacturing, and more.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY